Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 121

1.

Feasibility of a tandem autologous peripheral blood stem cell transplant regimen for high risk neuroblastoma in a cooperative group setting: a Pediatric Oncology Group study: a report from the Children's Oncology Group.

Granger M, Grupp SA, Kletzel M, Kretschmar C, Naranjo A, London WB, Diller L.

Pediatr Blood Cancer. 2012 Nov;59(5):902-7. doi: 10.1002/pbc.24207. Epub 2012 Jun 28.

PMID:
22744917
[PubMed - indexed for MEDLINE]
2.

Tandem stem cell rescue as consolidation therapy for high-risk neuroblastoma.

Qayed M, Chiang KY, Ricketts R, Alazraki A, Tahvildari A, Haight A, George B, Esiashvili N, Katzenstein HM.

Pediatr Blood Cancer. 2012 Mar;58(3):448-52. doi: 10.1002/pbc.23155. Epub 2011 Apr 29.

PMID:
21538822
[PubMed - indexed for MEDLINE]
3.

Primary tumor control in patients with stage 3/4 unfavorable neuroblastoma treated with tandem double autologous stem cell transplants.

Marcus KJ, Shamberger R, Litman H, von Allmen D, Grupp SA, Nancarrow CM, Goldwein J, Grier HE, Diller L.

J Pediatr Hematol Oncol. 2003 Dec;25(12):934-40.

PMID:
14663275
[PubMed - indexed for MEDLINE]
4.

Phase I study of tandem high-dose chemotherapy with autologous peripheral blood stem cell rescue for children with recurrent brain tumors: a Pediatric Blood and MarrowTransplant Consortium study.

Gilman AL, Jacobsen C, Bunin N, Levine J, Goldman F, Bendel A, Joyce M, Anderson P, Rozans M, Wall DA, Macdonald TJ, Simon S, Kadota RP.

Pediatr Blood Cancer. 2011 Sep;57(3):506-13. doi: 10.1002/pbc.22899. Epub 2010 Dec 1.

PMID:
21744474
[PubMed - indexed for MEDLINE]
5.

High-risk neuroblastoma treated with tandem autologous peripheral-blood stem cell-supported transplantation: long-term survival update.

George RE, Li S, Medeiros-Nancarrow C, Neuberg D, Marcus K, Shamberger RC, Pulsipher M, Grupp SA, Diller L.

J Clin Oncol. 2006 Jun 20;24(18):2891-6.

PMID:
16782928
[PubMed - indexed for MEDLINE]
Free Article
6.

A pilot study of tandem high-dose chemotherapy with stem cell rescue as consolidation for high-risk neuroblastoma: Children's Oncology Group study ANBL00P1.

Seif AE, Naranjo A, Baker DL, Bunin NJ, Kletzel M, Kretschmar CS, Maris JM, McGrady PW, von Allmen D, Cohn SL, London WB, Park JR, Diller LR, Grupp SA.

Bone Marrow Transplant. 2013 Jul;48(7):947-52. doi: 10.1038/bmt.2012.276. Epub 2013 Jan 21.

PMID:
23334272
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Treatment of high-risk neuroblastoma with triple-tandem high-dose therapy and stem-cell rescue: results of the Chicago Pilot II Study.

Kletzel M, Katzenstein HM, Haut PR, Yu AL, Morgan E, Reynolds M, Geissler G, Marymount MH, Liu D, Kalapurakal JA, Shore RM, Bardo DM, Schmoldt J, Rademaker AW, Cohn SL.

J Clin Oncol. 2002 May 1;20(9):2284-92.

PMID:
11980999
[PubMed - indexed for MEDLINE]
Free Article
8.

Rapid-sequence tandem transplant for children with high-risk neuroblastoma.

Grupp SA, Stern JW, Bunin N, Nancarrow C, Adams R, Gorlin JB, Griffin G, Diller L.

Med Pediatr Oncol. 2000 Dec;35(6):696-700.

PMID:
11107149
[PubMed - indexed for MEDLINE]
9.

Tandem high-dose therapy in rapid sequence for children with high-risk neuroblastoma.

Grupp SA, Stern JW, Bunin N, Nancarrow C, Ross AA, Mogul M, Adams R, Grier HE, Gorlin JB, Shamberger R, Marcus K, Neuberg D, Weinstein HJ, Diller L.

J Clin Oncol. 2000 Jul;18(13):2567-75.

PMID:
10893288
[PubMed - indexed for MEDLINE]
Free Article
10.

Thiotepa and melphalan based single, tandem, and triple high dose therapy and autologous stem cell transplantation for high risk neuroblastoma.

Saarinen-Pihkala UM, Hovi L, Koivusalo A, Jahnukainen K, Karikoski R, Sariola H, Wikström S.

Pediatr Blood Cancer. 2012 Dec 15;59(7):1190-7. doi: 10.1002/pbc.24173. Epub 2012 Apr 10.

PMID:
22492714
[PubMed - indexed for MEDLINE]
11.

Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): a randomised phase 3 trial.

Kreissman SG, Seeger RC, Matthay KK, London WB, Sposto R, Grupp SA, Haas-Kogan DA, Laquaglia MP, Yu AL, Diller L, Buxton A, Park JR, Cohn SL, Maris JM, Reynolds CP, Villablanca JG.

Lancet Oncol. 2013 Sep;14(10):999-1008. doi: 10.1016/S1470-2045(13)70309-7. Epub 2013 Jul 25.

PMID:
23890779
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

A short course of induction chemotherapy followed by two cycles of high-dose chemotherapy with stem cell rescue for chemotherapy naive metastatic breast cancer.

Elias AD, Richardson P, Avigan D, Ibrahim J, Joyce R, Demetri G, Levine J, Warren D, Arthur T, Reich E, Wheele C, Frei E 3rd, Ayash L.

Bone Marrow Transplant. 2001 Feb;27(3):269-78.

PMID:
11277174
[PubMed - indexed for MEDLINE]
Free Article
13.

Thiotepa and cyclophosphamide with stem cell rescue for consolidation therapy for children with high-risk neuroblastoma: a phase I/II study of the Pediatric Blood and Marrow Transplant Consortium.

Kletzel M, Abella EM, Sandler ES, Williams LL, Ogden AK, Pollock BH, Wall DA.

J Pediatr Hematol Oncol. 1998 Jan-Feb;20(1):49-54.

PMID:
9482413
[PubMed - indexed for MEDLINE]
14.

Improved survival of children with advanced neuroblastoma treated by intensified therapy including myeloablative chemotherapy with stem cell transplantation: a retrospective analysis from the Tohoku Neuroblastoma Study Group.

Imaizumi M, Watanabe A, Kikuta A, Takano T, Ito E, Shimizu T, Tsuchiya S, Iinuma K, Konno T, Ohi R, Hayashi Y; Tohoku Neuroblastoma Study Group.

Tohoku J Exp Med. 2001 Oct;195(2):73-83.

PMID:
11846211
[PubMed - indexed for MEDLINE]
Free Article
15.

Analysis of pediatric autologous PBSC apheresis and transplant: age is a major factor affecting post-transplant toxicity.

Dubrovsky L, McCarter RJ, Fry TJ, Wong E, Cheng Y, Perez-Albuerne ED.

Pediatr Blood Cancer. 2012 Aug;59(2):301-5. doi: 10.1002/pbc.24026. Epub 2011 Dec 16.

PMID:
22180259
[PubMed - indexed for MEDLINE]
16.

A novel intensive induction therapy for high-risk neuroblastoma utilizing sequential peripheral blood stem cell collection and infusion as hematopoietic support.

Pradhan KR, Johnson CS, Vik TA, Sender LS, Kreissman SG.

Pediatr Blood Cancer. 2006 Jun;46(7):793-802.

PMID:
16206215
[PubMed - indexed for MEDLINE]
17.

Outcome for children <4 years of age with malignant central nervous system tumors treated with high-dose chemotherapy and autologous stem cell rescue.

Thorarinsdottir HK, Rood B, Kamani N, Lafond D, Perez-Albuerne E, Loechelt B, Packer RJ, MacDonald TJ.

Pediatr Blood Cancer. 2007 Mar;48(3):278-84.

PMID:
16456857
[PubMed - indexed for MEDLINE]
18.

Aggressive surgical therapy and radiotherapy for patients with high-risk neuroblastoma treated with rapid sequence tandem transplant.

von Allmen D, Grupp S, Diller L, Marcus K, Ecklund K, Meyer J, Shamberger RC.

J Pediatr Surg. 2005 Jun;40(6):936-41; discussion 941.

PMID:
15991174
[PubMed - indexed for MEDLINE]
19.
20.

A dose-intensive approach (NB96) for induction therapy utilizing sequential high-dose chemotherapy and stem cell rescue in high-risk neuroblastoma in children over 1 year of age.

Monnereau-Laborde S, Munzer C, Valteau-Couanet D, Ansoborlo S, Coze C, Chastagner P, Rubie H, Demeocq F, Stephan JL, Hartmann O, Perel Y.

Pediatr Blood Cancer. 2011 Dec 1;57(6):965-71. doi: 10.1002/pbc.23232. Epub 2011 Jul 8.

PMID:
21744481
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk